The HK Market's Island of Misfit Toys: Who is Pivoting and Who is Sleepwalking?Global Report·Jul 29 at 04:18 AM02197+1.86%02408-2.75%
Clover Biopharmaceuticals Signals Interim Profit on One-Off Gavi Settlement GainTip Ranks·Jul 19 at 06:07 PM02197+1.86%
The Island of Misfit Stocks: From Elon's Giga Press to Real Estate DefaultsGlobal Report·Jul 17 at 04:12 AM02877-1.18%01685-3.65%
The Economics of the Long Tail: Structural Survival in Hong Kong's Bifurcated MarketGlobal Report·Jul 8 at 10:32 PM08507-1.91%01051-0.84%
Clover Biopharma shareholders adopt financial statements, re-elect directors at AGMPUBT·Jun 18 at 08:57 AM02197+1.86%
Clover Biopharmaceuticals Details Capped Payment Deal With Gavi, Easing US$224 Million ExposureTip Ranks·Apr 2 at 06:00 AM02197+1.86%FBT+0.18%
Clover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory VaccinesTip Ranks·Mar 29 at 05:39 PM513120+2.56%5606000.00%
Clover Biopharmaceuticals Strikes Cap-Limited Settlement With Gavi to End ArbitrationTip Ranks·Mar 22 at 07:07 AM02197+1.86%513120+2.56%
Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider DividendTip Ranks·Mar 13 at 06:10 AM159615+2.37%IBBQ-0.37%
Hong Kong stock pharmaceutical stocks strengthened, with ASCLETIS-B rising over 9%, CLOVER BIO-B rising over 8%, WUXI BIO rising nearly 7%, and CARSGEN-B rising over 5%Wallstreetcn·Dec 4, 2025 at 12:46 AM02197+1.86%WXXWY+0.20%
